Glycodiversification for the Synthesis of Kanamycin and Neomycin Class Aminoglycoside Antibiotics
Document Type
Contribution to Book
Journal/Book Title
Frontiers in Modern Carbohydrate Chemistry
Publication Date
3-13-2007
First Page
307
Last Page
327
Abstract
Aminoglycosides are an important resource against infectious diseases. However, the prevalence of aminoglycoside resistant bacteria has limited their use and resulted in the need for novel aminoglycosides. Our group has synthesized two libraries of aminoglycosides: pyranmycin and kanamycin analogs, utilizing the glycodiversification concept. Several of them show promising activity against both susceptible and resistant strains of E. coli. The structure activity relationship of these compounds further provides information for the future designs of aminoglycoside.
Recommended Citation
Wang, J.; Chang, C.-W. T. “Glycodiversification for the Synthesis of Kanamycin and Neomycin Class Aminoglycoside Antibiotics.” in Frontiers in Carbohydrate Chemistry, Demchenko, A. Ed. ACS Symposium Series, volume 960, 2007, p307-327.
